Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (251-260 of 692) with videos related to

Pageof 70
Sort By:
Dementia (London, England)|November 24, 2023
Vascular cognitive impairment: When memory loss is not the biggest challengeSara Aj van de Schraaf, Merel F Smit, Majon Muller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2011
Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studiesFloris H P van Velden, Patsuree Cheebsumon, Maqsood Yaqub, et al.
Plant Physiology and Biochemistry : PPB|March 14, 2009
Effect of trifluoroacetate, a persistent degradation product of fluorinated hydrocarbons, on Phaseolus vulgaris and Zea maysMartin F Smit, Philippus D R van Heerden, Jakobus J Pienaar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?C Dickhoff, K J Hartemink, J Kooij, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018
Variability and Repeatability of Quantitative Uptake Metrics in <sup>18</sup>F-FDG PET/CT of Non-Small Cell Lung Cancer: Impact of Segmentation Method, Uptake Interval, and Reconstruction ProtocolMingzan Zhuang, David Vállez García, Gerbrand M Kramer, et al.
Expert Review of Anticancer Therapy|February 5, 2026
The role of zongertinib, a highly selective tyrosine kinase inhibitor, in targeting <i>HER2</i>-mutant NSCLC: a bench-to-bedside reviewJohn V Heymach, Sanjay Popat, Egbert F Smit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 11, 2013
Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgeryGwendolyn H M J Griffioen, Frank J Lagerwaard, Cornelis J A Haasbeek, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief reportEgbert F Smit, Anne-Marie C Dingemans, Frederik B Thunnissen, et al.
International Journal of Otolaryngology|January 10, 2012
Cochlear implantation after bacterial meningitis in infants younger than 9 monthsB Y Roukema, M C Van Loon, C Smits, et al.
Oncoimmunology|May 1, 2023
Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodesFrank J Borm, Jasper Smit, Joyce Bakker, et al.
Pageof 70

Showing results (251-260 of 692) with videos related to

Sort By:
Pageof 70
Dementia (London, England)|November 24, 2023
Vascular cognitive impairment: When memory loss is not the biggest challengeSara Aj van de Schraaf, Merel F Smit, Majon Muller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2011
Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studiesFloris H P van Velden, Patsuree Cheebsumon, Maqsood Yaqub, et al.
Plant Physiology and Biochemistry : PPB|March 14, 2009
Effect of trifluoroacetate, a persistent degradation product of fluorinated hydrocarbons, on Phaseolus vulgaris and Zea maysMartin F Smit, Philippus D R van Heerden, Jakobus J Pienaar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?C Dickhoff, K J Hartemink, J Kooij, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018
Variability and Repeatability of Quantitative Uptake Metrics in <sup>18</sup>F-FDG PET/CT of Non-Small Cell Lung Cancer: Impact of Segmentation Method, Uptake Interval, and Reconstruction ProtocolMingzan Zhuang, David Vállez García, Gerbrand M Kramer, et al.
Expert Review of Anticancer Therapy|February 5, 2026
The role of zongertinib, a highly selective tyrosine kinase inhibitor, in targeting <i>HER2</i>-mutant NSCLC: a bench-to-bedside reviewJohn V Heymach, Sanjay Popat, Egbert F Smit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 11, 2013
Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgeryGwendolyn H M J Griffioen, Frank J Lagerwaard, Cornelis J A Haasbeek, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief reportEgbert F Smit, Anne-Marie C Dingemans, Frederik B Thunnissen, et al.
International Journal of Otolaryngology|January 10, 2012
Cochlear implantation after bacterial meningitis in infants younger than 9 monthsB Y Roukema, M C Van Loon, C Smits, et al.
Oncoimmunology|May 1, 2023
Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodesFrank J Borm, Jasper Smit, Joyce Bakker, et al.
Pageof 70